Intervention Review

Intermediate acting versus long acting insulin for type 1 diabetes mellitus

  1. Moshe Vardi1,*,
  2. Eyal Jacobson2,
  3. Asaph Nini3,
  4. Haim Bitterman4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 30 SEP 2007

DOI: 10.1002/14651858.CD006297.pub2

How to Cite

Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006297. DOI: 10.1002/14651858.CD006297.pub2.

Author Information

  1. 1

    Carmel Medical Center, Internal Medicine, Haifa, Israel

  2. 2

    Clalit Health Services, Haifa and Western Galilee District, Department of Family Medicine, Haifa, Israel

  3. 3

    Sheba Medical Center, Intensive Care Unit, Tel Hashomer, Israel

  4. 4

    Carmel Lady Davis Medical Center, Internal Medicine, Haifa, Israel

*Moshe Vardi, Internal Medicine, Carmel Medical Center, 7 Michal St, Haifa, Haifa, 34362, Israel. MosheVa3@clalit.org.il.

Publication History

  1. Publication Status: New
  2. Published Online: 16 JUL 2008

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >